Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers ; volume:8 ; number:1 ; day:29 ; month:1 ; year:2018 ; pages:1-8 ; date:12.2018
Scientific reports ; 8, Heft 1 (29.1.2018), 1-8, 12.2018
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Novo, Mercedes
- Beteiligte Personen und Organisationen
-
Freire, Sonia
Al-Soufi, Wajih
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-19961-3
- URN
-
urn:nbn:de:1111-201804137476
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Novo, Mercedes
- Freire, Sonia
- Al-Soufi, Wajih
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stability of single and double layer fibrillar amyloid-β oligomers
Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
Bifurcations in coupled amyloid-β aggregation-inflammation systems
Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
β-Turn mimetic synthetic peptides as amyloid-β aggregation inhibitors
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Aggregation Mechanisms and Molecular Structures of Amyloid‐β in Alzheimer's Disease
Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease
Origins of amyloid-β
Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers
Stability of single and double layer fibrillar amyloid-β oligomers
Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
Bifurcations in coupled amyloid-β aggregation-inflammation systems
Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
β-Turn mimetic synthetic peptides as amyloid-β aggregation inhibitors
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Aggregation Mechanisms and Molecular Structures of Amyloid‐β in Alzheimer's Disease
Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease
Origins of amyloid-β
Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers
Stability of single and double layer fibrillar amyloid-β oligomers
Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
Bifurcations in coupled amyloid-β aggregation-inflammation systems
Amyloid-β Oligomers Regulate ADAM10 Synaptic Localization Through Aberrant Plasticity Phenomena
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
β-Turn mimetic synthetic peptides as amyloid-β aggregation inhibitors
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Aggregation Mechanisms and Molecular Structures of Amyloid‐β in Alzheimer's Disease
Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease
Origins of amyloid-β